Know Cancer

or
forgot password

    • cancer clinical trials in royal oak, MI

    • Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
    William Beaumont Hospital - Royal Oak
    Royal Oak, Michigan 48073-6769
    Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Prostate Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Melanoma (Skin)
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    William Beaumont Hospital

    Trial Locations
    William Beaumont Hospital
    CCOP - Beaumont
    Head and Neck Cancer
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    William Beaumont Hospital

    Trial Locations
    William Beaumont Hospital
    CCOP - Beaumont
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    CCOP - Beaumont

    Trial Locations
    CCOP - Beaumont
    William Beaumont Hospital - Royal Oak
    Sarcoma
    STI571 in Treating Patients With Recurrent Leukemia
    CCOP - Beaumont
    Royal Oak, Michigan 48073-6769
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    CCOP - Beaumont

    Trial Locations
    CCOP - Beaumont
    William Beaumont Hospital - Royal Oak
    Prostate Cancer
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    CCOP - Beaumont
    Royal Oak, Michigan 48073-6769
    Brain and Central Nervous System Tumors
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    William Beaumont Hospital

    Trial Locations
    William Beaumont Hospital
    CCOP - Beaumont
    Brain and Central Nervous System Tumors
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Lung Cancer
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    William Beaumont Hospital

    Trial Locations
    William Beaumont Hospital
    CCOP - Beaumont
    Head and Neck Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Esophageal Cancer, Gastric Cancer
    Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Endometrial Cancer
    S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Multiple Myeloma and Plasma Cell Neoplasm
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Lymphoma
    Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Lung Cancer, Pulmonary Complications, Radiation Fibrosis
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    CCOP - Beaumont

    Trial Locations
    CCOP - Beaumont
    William Beaumont Hospital - Royal Oak
    Kidney Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Liver Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Fallopian Tube Cancer, Ovarian Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Royal Oak, Michigan 48073
    Neoplasms, Breast
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    William Beaumont Hospital - Royal Oak Campus
    Royal Oak, Michigan 48073
    Head and Neck Cancer
    ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
    GSK Investigational Site
    Royal Oak, Michigan 48073
    Neoplasms, Breast
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    William Beaumont Hospital
    Royal Oak, Michigan 48073
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer